Glenmark Pharmaceuticals recalls 20 mg Nebivolol tablets due to cross contamination risk. Affected lots manufactured in India with specific expiration date. Consumers should check product details and contact for guidance.
“Glenmark Nebivolol Tablets Recall: Cross Contamination Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31634-glenmark-nebivolol-tablets-recall-cross-contamination-hazard. Based on FDA recall #D-0222-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0222-2026%22&limit=1).
The FDA announced on Nov. 18, 2025, that Glenmark Pharmaceuticals Inc., USA voluntarily recalled Nebivolol Tablets, 20 mg, due to cross-contamination with other products. The recall affects 672 bottles distributed nationwide.
How to tell if you have it
Brand: Glenmark
Product: Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only
NDC: 42291-874-90
Lot#: 17240988
Expiration Date: 05/31/2026
Quantity: 672 bottles of 90-count
Distribution: U.S. Nationwide
The hazard
The recall was initiated because the Nebivolol Tablets were cross-contaminated with other products, according to the FDA.
Context
GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since 2017-11-20. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (2026-07-23), Glenmark Alyacen Birth Control Tablets Recall (2026-05-27), and Glenmark Ondansetron Tablets Recall (2025-12-30). Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (2026-06-26), Golden State Medical Supply Primidone Tablets Recall (2026-04-27), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (2026-01-21).
How to tell if you have this one
Check for the lot number 17240988 on the packaging. The tablets were manufactured in India with an expiration date of May 31, 2026.
Brand
Glenmark
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 17240988 on the packaging to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 29 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0222-2026 (November 18, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0222-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.